COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries
Since December 2019, the world has been facing one of the most critical health threats of the last decades. In March 2021, the official number of deaths passed 2.6 million worldwide. Most countries have developed policies to control the disease. Nevertheless, countries have experienced different out...
Gespeichert in:
Veröffentlicht in: | Archives of Iranian medicine 2021-03, Vol.24 (3), p.260-272 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 272 |
---|---|
container_issue | 3 |
container_start_page | 260 |
container_title | Archives of Iranian medicine |
container_volume | 24 |
creator | Raoofi, Azam Takian, Amirhossein Haghighi, Hajar Rajizadeh, Afsaneh Rezaei, Zeinab Radmerikhi, Samera Olyaeemanesh, Alireza Akbari Sari, Ali |
description | Since December 2019, the world has been facing one of the most critical health threats of the last decades. In March 2021, the official number of deaths passed 2.6 million worldwide. Most countries have developed policies to control the disease. Nevertheless, countries have experienced different outcomes related to their various adapted policies. Complementing our first report, in this article, we report our findings of comparing the policies adopted to combat coronavirus disease 2019 (COVID-19) in Iran, with those from nine selected countries, including China, Japan, South Korea, Singapore, Germany, the United States, the United Kingdom, Spain, and Italy, to draw evidence-informed policy lessons.
This is a qualitative study conducted based on document analysis related to COVID-19 policies in Iran and nine selected countries. Using a deductive approach, data were extracted and analyzed based on the components of the WHO Building Blocks Framework. Finally, we compared the Iranian policies with the nine selected countries.
Documents analysis revealed a spectrum of policies, which have led to a variety of outcomes. Based on our findings, three main strategies (widespread testing, comprehensive contact tracing, and timely measures) were the most effective directions to combat COVID-19.
The experience of the first and second waves of COVID-19 showed that the risk of coronavirus is serious and will continue until a vaccine or decisive treatment is achieved. Therefore, countries are required to adopt appropriate and tailored policies to deal with this crisis effectively. Applying the experiences from the previous waves is essential for more efficient performance in the likely upcoming waves. |
doi_str_mv | 10.34172/aim.2021.37 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2642357304</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2642357304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-30c5716a80072d76a3f11713e650981420911e3a4b1cf10789a684493f52e1933</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0EoqVw44wscSXF63ViW5xQKLRSpXIArpabOjRV88BJEP33GFo47Wo1O6P5CLkENkYBkt_aohxzxmGM8ogMQWIcoRbyOOyM64hrKQfkrG03jAmMAU_JAFFJpZQYkkW6eJs9RKCprVY0rcvGetsVn45Ond12a_pcb4tsR-fO-qqo3u9ot3Z08tU4X7gqc7TOKbDw2FdduLTn5CS329ZdHOaIvD5OXtJpNF88zdL7eZRhLLsIWRZLSKxiTPKVTCzmABLQJTHTCgRnGsChFUvIcmBSaZsoITTmMXegEUfkeu_b-Pqjd21nNnXvqxBpeCJ4CMHQdkRu9qrM123rXW4aX5TW7www80vPBHrmh55BGeRXB9N-WbrVv_gPF34D_WRmWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2642357304</pqid></control><display><type>article</type><title>COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Raoofi, Azam ; Takian, Amirhossein ; Haghighi, Hajar ; Rajizadeh, Afsaneh ; Rezaei, Zeinab ; Radmerikhi, Samera ; Olyaeemanesh, Alireza ; Akbari Sari, Ali</creator><creatorcontrib>Raoofi, Azam ; Takian, Amirhossein ; Haghighi, Hajar ; Rajizadeh, Afsaneh ; Rezaei, Zeinab ; Radmerikhi, Samera ; Olyaeemanesh, Alireza ; Akbari Sari, Ali</creatorcontrib><description>Since December 2019, the world has been facing one of the most critical health threats of the last decades. In March 2021, the official number of deaths passed 2.6 million worldwide. Most countries have developed policies to control the disease. Nevertheless, countries have experienced different outcomes related to their various adapted policies. Complementing our first report, in this article, we report our findings of comparing the policies adopted to combat coronavirus disease 2019 (COVID-19) in Iran, with those from nine selected countries, including China, Japan, South Korea, Singapore, Germany, the United States, the United Kingdom, Spain, and Italy, to draw evidence-informed policy lessons.
This is a qualitative study conducted based on document analysis related to COVID-19 policies in Iran and nine selected countries. Using a deductive approach, data were extracted and analyzed based on the components of the WHO Building Blocks Framework. Finally, we compared the Iranian policies with the nine selected countries.
Documents analysis revealed a spectrum of policies, which have led to a variety of outcomes. Based on our findings, three main strategies (widespread testing, comprehensive contact tracing, and timely measures) were the most effective directions to combat COVID-19.
The experience of the first and second waves of COVID-19 showed that the risk of coronavirus is serious and will continue until a vaccine or decisive treatment is achieved. Therefore, countries are required to adopt appropriate and tailored policies to deal with this crisis effectively. Applying the experiences from the previous waves is essential for more efficient performance in the likely upcoming waves.</description><identifier>ISSN: 1029-2977</identifier><identifier>EISSN: 1735-3947</identifier><identifier>DOI: 10.34172/aim.2021.37</identifier><identifier>PMID: 33878884</identifier><language>eng</language><publisher>Iran: Academy of Medical Sciences of I.R. Iran</publisher><subject>Asia - epidemiology ; Contact Tracing ; Coronaviruses ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; COVID-19 - prevention & control ; COVID-19 Testing ; COVID-19 Vaccines ; Disease control ; Europe - epidemiology ; Global health ; Health care policy ; Health Policy ; Humans ; Iran - epidemiology ; Pandemics ; Physical Distancing ; Qualitative Research ; Quarantine ; Shelter in place ; United States - epidemiology</subject><ispartof>Archives of Iranian medicine, 2021-03, Vol.24 (3), p.260-272</ispartof><rights>2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-30c5716a80072d76a3f11713e650981420911e3a4b1cf10789a684493f52e1933</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33878884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raoofi, Azam</creatorcontrib><creatorcontrib>Takian, Amirhossein</creatorcontrib><creatorcontrib>Haghighi, Hajar</creatorcontrib><creatorcontrib>Rajizadeh, Afsaneh</creatorcontrib><creatorcontrib>Rezaei, Zeinab</creatorcontrib><creatorcontrib>Radmerikhi, Samera</creatorcontrib><creatorcontrib>Olyaeemanesh, Alireza</creatorcontrib><creatorcontrib>Akbari Sari, Ali</creatorcontrib><title>COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries</title><title>Archives of Iranian medicine</title><addtitle>Arch Iran Med</addtitle><description>Since December 2019, the world has been facing one of the most critical health threats of the last decades. In March 2021, the official number of deaths passed 2.6 million worldwide. Most countries have developed policies to control the disease. Nevertheless, countries have experienced different outcomes related to their various adapted policies. Complementing our first report, in this article, we report our findings of comparing the policies adopted to combat coronavirus disease 2019 (COVID-19) in Iran, with those from nine selected countries, including China, Japan, South Korea, Singapore, Germany, the United States, the United Kingdom, Spain, and Italy, to draw evidence-informed policy lessons.
This is a qualitative study conducted based on document analysis related to COVID-19 policies in Iran and nine selected countries. Using a deductive approach, data were extracted and analyzed based on the components of the WHO Building Blocks Framework. Finally, we compared the Iranian policies with the nine selected countries.
Documents analysis revealed a spectrum of policies, which have led to a variety of outcomes. Based on our findings, three main strategies (widespread testing, comprehensive contact tracing, and timely measures) were the most effective directions to combat COVID-19.
The experience of the first and second waves of COVID-19 showed that the risk of coronavirus is serious and will continue until a vaccine or decisive treatment is achieved. Therefore, countries are required to adopt appropriate and tailored policies to deal with this crisis effectively. Applying the experiences from the previous waves is essential for more efficient performance in the likely upcoming waves.</description><subject>Asia - epidemiology</subject><subject>Contact Tracing</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 Testing</subject><subject>COVID-19 Vaccines</subject><subject>Disease control</subject><subject>Europe - epidemiology</subject><subject>Global health</subject><subject>Health care policy</subject><subject>Health Policy</subject><subject>Humans</subject><subject>Iran - epidemiology</subject><subject>Pandemics</subject><subject>Physical Distancing</subject><subject>Qualitative Research</subject><subject>Quarantine</subject><subject>Shelter in place</subject><subject>United States - epidemiology</subject><issn>1029-2977</issn><issn>1735-3947</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kEtPwzAQhC0EoqVw44wscSXF63ViW5xQKLRSpXIArpabOjRV88BJEP33GFo47Wo1O6P5CLkENkYBkt_aohxzxmGM8ogMQWIcoRbyOOyM64hrKQfkrG03jAmMAU_JAFFJpZQYkkW6eJs9RKCprVY0rcvGetsVn45Ond12a_pcb4tsR-fO-qqo3u9ot3Z08tU4X7gqc7TOKbDw2FdduLTn5CS329ZdHOaIvD5OXtJpNF88zdL7eZRhLLsIWRZLSKxiTPKVTCzmABLQJTHTCgRnGsChFUvIcmBSaZsoITTmMXegEUfkeu_b-Pqjd21nNnXvqxBpeCJ4CMHQdkRu9qrM123rXW4aX5TW7www80vPBHrmh55BGeRXB9N-WbrVv_gPF34D_WRmWA</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Raoofi, Azam</creator><creator>Takian, Amirhossein</creator><creator>Haghighi, Hajar</creator><creator>Rajizadeh, Afsaneh</creator><creator>Rezaei, Zeinab</creator><creator>Radmerikhi, Samera</creator><creator>Olyaeemanesh, Alireza</creator><creator>Akbari Sari, Ali</creator><general>Academy of Medical Sciences of I.R. Iran</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20210301</creationdate><title>COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries</title><author>Raoofi, Azam ; Takian, Amirhossein ; Haghighi, Hajar ; Rajizadeh, Afsaneh ; Rezaei, Zeinab ; Radmerikhi, Samera ; Olyaeemanesh, Alireza ; Akbari Sari, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-30c5716a80072d76a3f11713e650981420911e3a4b1cf10789a684493f52e1933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Asia - epidemiology</topic><topic>Contact Tracing</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 Testing</topic><topic>COVID-19 Vaccines</topic><topic>Disease control</topic><topic>Europe - epidemiology</topic><topic>Global health</topic><topic>Health care policy</topic><topic>Health Policy</topic><topic>Humans</topic><topic>Iran - epidemiology</topic><topic>Pandemics</topic><topic>Physical Distancing</topic><topic>Qualitative Research</topic><topic>Quarantine</topic><topic>Shelter in place</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raoofi, Azam</creatorcontrib><creatorcontrib>Takian, Amirhossein</creatorcontrib><creatorcontrib>Haghighi, Hajar</creatorcontrib><creatorcontrib>Rajizadeh, Afsaneh</creatorcontrib><creatorcontrib>Rezaei, Zeinab</creatorcontrib><creatorcontrib>Radmerikhi, Samera</creatorcontrib><creatorcontrib>Olyaeemanesh, Alireza</creatorcontrib><creatorcontrib>Akbari Sari, Ali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Archives of Iranian medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raoofi, Azam</au><au>Takian, Amirhossein</au><au>Haghighi, Hajar</au><au>Rajizadeh, Afsaneh</au><au>Rezaei, Zeinab</au><au>Radmerikhi, Samera</au><au>Olyaeemanesh, Alireza</au><au>Akbari Sari, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries</atitle><jtitle>Archives of Iranian medicine</jtitle><addtitle>Arch Iran Med</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>24</volume><issue>3</issue><spage>260</spage><epage>272</epage><pages>260-272</pages><issn>1029-2977</issn><eissn>1735-3947</eissn><abstract>Since December 2019, the world has been facing one of the most critical health threats of the last decades. In March 2021, the official number of deaths passed 2.6 million worldwide. Most countries have developed policies to control the disease. Nevertheless, countries have experienced different outcomes related to their various adapted policies. Complementing our first report, in this article, we report our findings of comparing the policies adopted to combat coronavirus disease 2019 (COVID-19) in Iran, with those from nine selected countries, including China, Japan, South Korea, Singapore, Germany, the United States, the United Kingdom, Spain, and Italy, to draw evidence-informed policy lessons.
This is a qualitative study conducted based on document analysis related to COVID-19 policies in Iran and nine selected countries. Using a deductive approach, data were extracted and analyzed based on the components of the WHO Building Blocks Framework. Finally, we compared the Iranian policies with the nine selected countries.
Documents analysis revealed a spectrum of policies, which have led to a variety of outcomes. Based on our findings, three main strategies (widespread testing, comprehensive contact tracing, and timely measures) were the most effective directions to combat COVID-19.
The experience of the first and second waves of COVID-19 showed that the risk of coronavirus is serious and will continue until a vaccine or decisive treatment is achieved. Therefore, countries are required to adopt appropriate and tailored policies to deal with this crisis effectively. Applying the experiences from the previous waves is essential for more efficient performance in the likely upcoming waves.</abstract><cop>Iran</cop><pub>Academy of Medical Sciences of I.R. Iran</pub><pmid>33878884</pmid><doi>10.34172/aim.2021.37</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1029-2977 |
ispartof | Archives of Iranian medicine, 2021-03, Vol.24 (3), p.260-272 |
issn | 1029-2977 1735-3947 |
language | eng |
recordid | cdi_proquest_journals_2642357304 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Asia - epidemiology Contact Tracing Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 Testing COVID-19 Vaccines Disease control Europe - epidemiology Global health Health care policy Health Policy Humans Iran - epidemiology Pandemics Physical Distancing Qualitative Research Quarantine Shelter in place United States - epidemiology |
title | COVID-19 and Comparative Health Policy Learning; the Experience of 10 Countries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20and%20Comparative%20Health%20Policy%20Learning;%20the%20Experience%20of%2010%20Countries&rft.jtitle=Archives%20of%20Iranian%20medicine&rft.au=Raoofi,%20Azam&rft.date=2021-03-01&rft.volume=24&rft.issue=3&rft.spage=260&rft.epage=272&rft.pages=260-272&rft.issn=1029-2977&rft.eissn=1735-3947&rft_id=info:doi/10.34172/aim.2021.37&rft_dat=%3Cproquest_cross%3E2642357304%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2642357304&rft_id=info:pmid/33878884&rfr_iscdi=true |